1. A MULTICENTER, OPEN LABEL, UNCONTROLLED, PHASE II TRIAL EVALUATING SAFETY AND EFFICACY OF VENETOCLAX, ATEZOLIZUMAB ANDOBINUTUZUMAB IN RICHTER TRANSFORMATION FROM CLL. (12th June 2019) Authors: Montillo, M.; Rossi, D.; Zucca, E.; Frustaci, A.M.; Pileri, S.; Cavalli, F.; Tedeschi, A. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 557 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗